Acute respitatory distress syndrome

Disease-a-Month

Volumn 42, Issue 5, 1996, Pages 270-326

  Schuster, Daniel P ^a   Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; PATHOPHYSIOLOGY; REVIEW; ARTIFICIAL VENTILATION; CLINICAL EXAMINATION; DISEASE COURSE; DISEASE SEVERITY; LUNG MECHANICS; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; THORAX RADIOGRAPHY;

HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIOXIDANT; CORTICOSTEROID; IBUPROFEN; INDOMETACIN; KETOCONAZOLE; LUNG SURFACTANT; METHYLPREDNISOLONE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; VASODILATOR AGENT;

EID: 0030138350     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(96)90016-4     Document Type: Review

References (180)

1. An international randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS
2. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993
3. The adult respiratory distress syndrome: a report of survival and modifying factors
4. The American-European Consensus Conference on ARDS: Definitions, mechanism , relevant outcomes, and clinical trial coordination
5. What is acute lung injury? What is ARDS?
6. The prognosis of the adult respiratory distress syndrome: inappropriate pessimism?
7. Distribution of regional density and vascular permeability in the adult respiratory distress syndrome
8. Computed tomography scanning in acute respiratory failure
9. An expanded definition of the adult respiratory distress syndrome
10. Identification of patients with acute lung injury: predictors of mortality
11. The value of edema protein measurements in patients with pulmonary edema
12. A positron emission tomography comparison of pulmonary vascular permeability during the adult respiratory distress syndrome and pneumonia
13. Pulmonary fibroproliferation and death in patients with late ARDS
14. Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure
15. Predicting outcome after ICU admission: the art and science of assessing risk
16. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany
17. Adult respiratory distress syndrome: risk with common predispositions
18. A prospective study of lung water measurements during patient management in an intensive care unit
19. The radiographic distinction of cardiogenic and noncardiogenic edema
20. The ARDS lung: new insights from computed tomography
21. The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema
22. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome
23. Permeability: theory vs practice in lung research
24. Pulmonary microvascular permeability to fluid and macromolecules
25. The clinical assessment of lung water
26. The measurement of lung water
27. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization
28. Pulmonary endothelial cell injury and altered lung metabolic function: early detection of the adult respiratory distress syndrome and possible functional significance
29. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilatorassociated pneumonia
30. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome
31. Lung mechanics in the adult respiratory distress syndrome: recent conceptual advances and implications for management
32. Pathology of the adult respiratory distress syndrome
33. Pulmonary pathology of the adult respiratory distress syndrome
34. Role of mesenchymal cell death in lung remodeling after injury
35. Pathobiology of pulmonary fibrosis
36. Idiopathic pulmonary fibrosis: a paradigm for lung injury and repair
37. Clinical risks for development of the acute respiratory distress syndrome
38. A multicenter registry of patients with acute respiratory distress syndrome
39. Clinical predictors of the adult respiratory distress syndrome
40. Multiorgan failure and infection in adult respiratory distress syndrome
41. Causes of mortality in patients with the adult respiratory distress syndrome
42. Incidence, site and outcome of infections in patients with the adult respiratory distress syndrome
43. Respiratory failure in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia
44. Acute respiratory failure due to Pneumocystis carinii pneumonia: clinical, radiographic and pathologic course
45. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome
46. Adult respiratory distress syndrome associated with miliary tuberculosis
47. Proteases and antiproteases in the adult respiratory distress syndrome
48. Oxidant injury to pulmonary endothelium
49. Neutrophils and the adult respiratory distress syndrome
50. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome: evidence for activated neutrophils in the pulmonary circulation
51. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia
52. Prevention of free radical mediated vascular permeability increase in lung using superoxide dismutase
53. Endothelial-leukocyte adhesion molecules
54. Pulmonary microvascular effects of arachidonic acid metabolites and their role in lung vascular injury
55. Adult respiratory distress syndrome in neutropenic patients
56. Occurrence of the adult respiratory distress syndrome in neutropenic patients
57. Mechanisms and mediators of the adult respiratory distress syndrome
58. Mechanisms of alveolar fibrosis after acute lung injury
59. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1, 8 and IL-6 levels are consistent and efficient predictors of outcome over time
60. Pulmonary vascular pathology: human and experimental studies
61. Mechanisms of lung vascular injury and edema after pulmonary microembolism
62. Lung ischemia-reperfusion injury in awake sheep: protection with verapamil
63. Lung reperfusion in dogs causes bilateral lung injury
64. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
65. Clinical measurement of extravascular lung water
66. Morphologic and physiologic correlates of increased extravascular lung water
67. Oxygenation as an indicator of lung fluid accumulation
68. On the absorption of fluids from the connective tissue spaces
69. Pathophysiology of pulmonary edema
70. Pulmonary edema: lung water balance in relation to physiologic monitoring and clinical outcome in the critically ill
71. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema
72. Increased sheep lung vascular permeability caused by Pseudomonas bacteria
73. Dynamics of edema and the safety factor against edema
74. Pulmonary edema in dogs, especially the sequence of fluid accumulation in the lungs
75. The pathogenesis of pulmonary edema
76. Resolution of pulmonary edema: mechanisms of liquid, protein, and cellular clearance from the lung
77. Re-expansion, re-oxygenation, and rethinking
78. Interstitial fluid pressure: negative pressure in the lung
79. Pulmonary edema associated with tocolytic therapy
80. Estimation of effective pulmonary capillary pressure in intact lungs
81. Noncardiogenic pulmonary edema following upper airway obstruction
82. “State-of-the-art” review: pathogenesis of pulmonary edema
83. Alveolar liquid and protein clearance in the absence of blood flow or ventilation in sheep
84. Effect of interstitial edema on lung lymph flow in goats in the absence of filtration
85. Edema clearance in isolated sheep lungs
86. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans
87. Long-term clearance of liquid and protein from the lungs of unanesthetized sheep
88. Alveolar liquid and protein clearance from normal dog lungs
89. Regulation of transport across pulmonary alveolar epithelial cell monolayers
90. Ventilation-perfusion distribution in the adult respiratory distress syndrome
91. Pulmonary gas exchange
92. The role of airflow resistance in patients with the adult respiratory distress syndrome
93. New options for the ventilatory management of acute lung injury
94. The acute respiratory distress syndrome
95. Building consensus on the use of mechanical ventilation
96. Re-targeting ventilatory objectives in adult respiratory distress syndrome
97. A physiologic approach to initiating, maintaining, and withdrawing mechanical ventilatory support during acute respiratory failure
98. Tidal volume reduction in ARDS: effect on cardiac output and arterial oxygenation
99. Early application of positive end-expiratory pressure in patients at risk for the adult respiratory distress syndrome
100. Titration of tidal volume and induced hypercapnia ina cute respiratory distress syndrome
101. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome
102. Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation
103. Cardiorespiratory effects of pressurecontrolled ventilation with and without inverse ratio in the adult respiratory distress syndrome
104. Inverse ratio ventilation in ARDS: rationale and implementation
105. Adult respiratory distress syndrome profiles by computed tomography
106. Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome: treatment with inverse ratio ventilation
107. Variations in inspiratory:expiratory ratio and airway pressure wave form during mechanical ventilation: the significance of mean airway pressure
108. Non-conventional techniques of ventilatory support
109. Comparison of high frequency jet ventilation to conventional mechanical ventilation during severe acute respiratory failure in humans
110. Comparison of high frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome
111. High-frequency jet ventilation: a prospective randomized evaluation
112. 2 clearance during mechanical ventilation
113. Perfluorocarbon-associated gasexchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study
114. Extracorporeal membrane oxygenation in severe acute respiratory failure
115. 2 removal for adult respiratory distress syndrome
116. Prolonged extra-corporeal support of gas exchange with an intravenacaval oxygenator
117. Mechanism by which the prone position improves oxygenation in acute lung injury
118. Use of extreme position changes in acute respiratory failure
119. Improved oxygenation in patients with acute respiratory failure: the prone position
120. The prone position in ARDS patients: a clinical study
121. Effects of induced hypothermia in patients with septic adult respiratory distress syndrome
122. Fluid balance and the adult respiratory distress syndrome
123. Elevation of systemic oxygen delivery in the treatment of critically ill patients
124. Surfactant and the adult respiratory distress syndrome
125. High dose corticosteroids in patients with the adult respiratory distress syndrome
126. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome
127. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure
128. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome
129. Antioxidant treatment with Nacetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study
130. Ketoconazole prevents acute respiratory failure in critically ill surgical patients
131. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation
132. Detection of circulating tumor necrosis factor after endotoxin administration
133. Prostacyclin and thromboxane A2 formation in increased human sepsis syndrome: effects of cyclooxygenase inhibition
134. Effect of ibuprofen in patients with severe sepsis: a randomized double-blind, multicenter study
135. Randomized double-blind, multicenter study of prostaglandin E in patients with the adult respiratory distress syndrome
136. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome
137. Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome
138. Anti-endotoxin therapies in septic shock. In: Natanson C, moderator. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
139. Efficacy and safety of monoclonal antibody to human tumor necrosis factor in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial
140. Diagnosis and treatment of pulmonary infections in adult respiratory distress syndrome
141. Effect of tidal volume on gas exchange and oxygen transport in the adult respiratory distress syndrome
142. Pulmonary barotrauma in mechanical ventilation: patterns and risk factors
143. Incidence of pulmonary barotrauma in a medical ICU
144. Pulmonary interstitial emphysema in the adult respiratory distress syndrome
145. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures
146. Oxygen toxicity
147. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study
148. Pressure controlled inverse ratio ventilation in severe adult respiratory failure
149. Effects of pressure-controlled ventilation with different I:E ratios versus volume-controlled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome
150. Oxygen delivery-consumption relationship in adult respiratory distress syndrome patients: the effects of sepsis
151. Should inverse ratio ventilation be used in adult respiratory distress syndrome
152. A successful computerized protocol for clinical management of pressure control inverse ratio ventilation in ARDS patients
153. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure
154. Oxygen delivery and consumption and ventricular preload are greater in survivors than in nonsurvivors of the adult respiratory distress syndrome
155. Oxygen supply and consumption in the adult respiratory distress syndrome
156. Role of oxygen debt in the development of organ failure, sepsis and death in high-risk surgical patients
157. Elevation of cardiac output and oxygen delivery improves outcome in septic shock
158. Nitroprusside infusion does not improve biventricular performance in patients with acute hypoxemic respiratory failure
159. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
160. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome
161. Inhaled nitric oxide for the adult respiratory distress syndrome
162. Indomethacin treatment following baboon endotoxin shock improves survival
163. Prolonged treatment with almitrine for refractory hypoxemia in adult respiratory distress syndrome
164. Ventilator-associated pneumonia: a multivariate analysis
165. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis
166. Mechanical ventilation
167. A critique of the ACCP Consensus Conference on Mechanical Ventilation
168. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure
169. Timing of tracheostomy in mechanically ventilated patients
170. Complications of acute respiratory failure
171. Elevated von Willebrand factor antigen is an early plasma predictor of impending acute lung injury in nonpulmonary sepsis syndrome
172. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality
173. Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death
174. 2 ratio and its differential response to conventional therapy
175. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome: a study in mechanically ventilated patients
176. Recovery of function in survivors of the acute respiratory distress syndrome
177. Pulmonary sequelae in survivors of the adult respiratory distress syndrome
178. Clinical determinants of abnormalities in pulmonary function in survivors of the adult respiratory distress syndrome
179. Impairment after adult respiratory distress syndrome: an evaluation based on American Thoracic Society recommendations